Raynaud's disease
- PMID: 3160308
- PMCID: PMC1777375
- DOI: 10.1136/adc.60.6.537
Raynaud's disease
Abstract
We report five children who presented with Raynaud's disease in whom we could find no clinical, haematological, or immunological evidence of a collagen disorder. Oral phenoxybenzamine proved useful for maintenance treatment in most, with infusions of prostacyclin, nitroprusside, and ketanserin during acute attacks.
Similar articles
-
Treatment of childhood Raynaud's disease by transdermal prostaglandin E2 analogue.Lancet. 1985 Jul 6;2(8445):50. doi: 10.1016/s0140-6736(85)90108-4. Lancet. 1985. PMID: 2861505 No abstract available.
-
Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.BMJ. 1989 Mar 4;298(6673):561-4. doi: 10.1136/bmj.298.6673.561. BMJ. 1989. PMID: 2467711 Free PMC article. Clinical Trial.
-
New prospects for the treatment of Raynaud's phenomenon using a serotoninergic S2 receptor antagonist (ketanserin) and stable derivatives of prostacyclin.Angiology. 1993 Feb;44(2):123-8. doi: 10.1177/000331979304400206. Angiology. 1993. PMID: 8434805 Clinical Trial.
-
Pharmacologic management of Raynaud's phenomenon.South Med J. 1984 Sep;77(9):1160-4. doi: 10.1097/00007611-198409000-00027. South Med J. 1984. PMID: 6385288 Review.
-
Raynaud's syndrome.BMJ. 1990 Mar 3;300(6724):553-5. doi: 10.1136/bmj.300.6724.553. BMJ. 1990. PMID: 1691027 Free PMC article. Review. No abstract available.
Cited by
-
Management of Raynaud's phenomenon. Focus on newer treatments.Drugs. 1989 May;37(5):700-12. doi: 10.2165/00003495-198937050-00005. Drugs. 1989. PMID: 2663416 Review.
-
Acrocyanosis due to imipramine.Arch Dis Child. 1988 Feb;63(2):204-5. doi: 10.1136/adc.63.2.204. Arch Dis Child. 1988. PMID: 3348672 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical